Prasad P, Verma S, Surbhi, Ganguly NK, Chaturvedi V, Mittal SA
Classification of dry eye disease subtypes
Obesity is now very common among patients with Crohns disease, yet there is limited guidance on how newer metabolic medications, particularly GLP-1 receptor agonists affect Crohns-related outcomes, presenting author Nakul Ganju, MD, an internal medicine resident at Howard University Hospital in Washington, DC, told GI & Hepatology News
Here are a few things consumers might want to keep in mind: 1
Any product-specific laboratory or consultation requirements are shown before purchase